Revance Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $2.4M | 780k | 3.04 |
| 2024-09-30 | $616k | 119k | 5.19 |
| 2024-06-30 | $946k | 368k | 2.57 |
| 2024-03-31 | $1.0M | 208k | 4.92 |
| 2023-12-31 | $5.2M | 593k | 8.79 |
| 2023-09-30 | $4.3M | 372k | 11.47 |
| 2023-06-30 | $5.9M | 233k | 25.31 |
| 2023-03-31 | $6.6M | 206k | 32.21 |
| 2022-12-31 | $7.1M | 383k | 18.46 |
| 2022-06-30 | $12M | 897k | 13.82 |
| 2022-03-31 | $17M | 850k | 19.50 |
| 2021-12-31 | $2.7M | 162k | 16.34 |
| 2021-09-30 | $11M | 376k | 27.86 |
| 2021-06-30 | $13M | 451k | 29.65 |
| 2021-03-31 | $8.6M | 309k | 27.95 |
| 2020-12-31 | $12M | 409k | 28.34 |
| 2020-09-30 | $16M | 630k | 25.14 |
| 2020-06-30 | $1.5M | 63k | 24.43 |
| 2020-03-31 | $1.1M | 71k | 14.83 |
| 2019-12-31 | $787k | 49k | 16.21 |
| 2019-09-30 | $2.3M | 174k | 13.00 |
| 2019-06-30 | $2.0M | 153k | 12.97 |
| 2019-03-31 | $3.7M | 233k | 15.76 |
| 2018-12-31 | $456k | 23k | 20.11 |
| 2018-09-30 | $3.2M | 128k | 24.85 |
| 2018-06-30 | $5.0M | 181k | 27.59 |
| 2018-03-31 | $3.2M | 102k | 30.80 |
| 2017-12-31 | $2.5M | 69k | 35.74 |
| 2017-09-30 | $443k | 16k | 27.50 |
| 2016-03-31 | $213k | 12k | 17.49 |
| 2014-12-31 | $846k | 50k | 16.92 |
| 2014-09-30 | $533k | 28k | 19.33 |
| 2014-06-30 | $4.3M | 125k | 34.00 |
| 2014-03-31 | $2.5M | 81k | 31.50 |